Trexquant Investment’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-13,810
| Closed | -$107K | – | 1158 |
|
|
2021
Q1 | $107K | Sell |
13,810
-6,403
| -32% | -$49.6K | 0.01% | 1051 |
|
|
2020
Q4 | $132K | Sell |
20,213
-57,550
| -74% | -$376K | 0.01% | 949 |
|
|
2020
Q3 | $517K | Sell |
77,763
-50,511
| -39% | -$336K | 0.03% | 666 |
|
|
2020
Q2 | $1.07M | Buy |
128,274
+109,863
| +597% | +$916K | 0.07% | 376 |
|
|
2020
Q1 | $141K | Buy |
+18,411
| New | +$141K | 0.01% | 1017 |
|
|
2019
Q4 | – | Sell |
-12,855
| Closed | -$95K | – | 1066 |
|
|
2019
Q3 | $95K | Buy |
12,855
+1,213
| +10% | +$8.96K | 0.01% | 813 |
|
|
2019
Q2 | $131K | Sell |
11,642
-20,888
| -64% | -$235K | 0.01% | 728 |
|
|
2019
Q1 | $350K | Buy |
+32,530
| New | +$350K | 0.02% | 695 |
|
|
2018
Q3 | – | Sell |
-19,670
| Closed | -$450K | – | 981 |
|
|
2018
Q2 | $450K | Sell |
19,670
-4,648
| -19% | -$106K | 0.03% | 568 |
|
|
2018
Q1 | $692K | Buy |
+24,318
| New | +$692K | 0.05% | 525 |
|
|
2017
Q4 | – | Sell |
-26,110
| Closed | -$474K | – | 1076 |
|
|
2017
Q3 | $474K | Buy |
+26,110
| New | +$474K | 0.12% | 293 |
|
|
2017
Q2 | – | Sell |
-60,979
| Closed | -$1.05M | – | 845 |
|
|
2017
Q1 | $1.05M | Buy |
60,979
+44,079
| +261% | +$761K | 0.14% | 236 |
|
|
2016
Q4 | $186K | Buy |
+16,900
| New | +$186K | 0.03% | 843 |
|